Episode 150: Ibogaine - Breakthrough or Risk?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
In this episode, Joseph and Paula explore ibogaine, an increasingly discussed and controversial substance in addiction treatment. They break down what ibogaine is, what it claims to do, and the current realities surrounding its use, including risks, legal status, and ethical considerations. With a focus on both curiosity and caution, this conversation invites counselors and listeners alike to think critically about emerging treatments and the evolving landscape of recovery.
Questions? If you have questions, you would like Joseph and Paula to address during an upcoming episode of Questions for Counselors, feel free to reach out through the website at www.lifelivedbetter.net or email them directly at Info@lifelivedbetter.net
You can find information about this and other episodes on the website: www.lifelivedbetter.net.
Just a reminder - Anything shared during this and all other episodes is based on personal experiences and opinions. It is not to be viewed as professional counseling or advice - it is solely our opinion. Information shared does not represent our employers or profession.
We would love for you to rate our show and tell others about us.
And remember, Knowledge leads to a Life Lived Better.
Resources used to create this episode:
ANR Clinic - Advanced Opioid Dependency Treatment Centers
Frontiers | Ibogaine Detoxification Transitions Opioid and Cocaine Abusers
Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
Ibogaine - Partnership to End Addiction
Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study - PMC
Study Details | NCT05029401 | A Study of Oral Ibogaine in Opioid Withdrawal | ClinicalTrials.gov
Trump takes page out of Texas lawmakers' book, signs executive order on ibogaine
UTHealth Houston, in collaboration with UTMB Health, awarded $50 million by the state of Texas to lead ibogaine clinical trials - UTHealth Houston